Research sheds new light on inflammatory disease

Apr 09, 2009

Scientists at the University of Liverpool have found that understanding the precise timing of communication between cells that coordinate the body's response to disease could be key to new drug developments.

Researchers, in collaboration with AstraZeneca and the Universities of Manchester and Warwick, are investigating the NF-kappa-B signalling system, which governs the responses within cells to stimuli such as stress and infection. It plays a central role in conditions such as cancer, , and asthma.

It was thought that blocking NF-kappa-B signals with drugs might alleviate these conditions, but scientists have now found that the timing of these signals can change cell behaviour and cause disease. The research suggests that drugs would need to change the timings in order to treat disease more effectively.

Professor Mike White, from the University's School of Biological Sciences, explains: "We know that the NF-kappa-B signalling system is a vital component of all cells and acts to control cell death and growth. When this system goes wrong, however, it can cause diseases such as cancer and inflammatory bowel disease. Currently, drugs target signal pathways and block them in order to treat diseases, but the NF-kappa-B system is so complex that the outcome of treatment is unpredictable.

"Our new research shows that the amount of NF-kappa-B in the nucleus of a cell varies in a wave-like pattern over time. It is the timing of these waves that can change the cell's behaviour and affect the development of disease. This means that instead of blocking the signal pathway, drugs need to change the timing of the waves to treat disease successfully."

Professor Douglas Kell, Chief Executive of the Biotechnology and Biological Sciences Research Council (BBSRC) and co-author of the research, added: "The results both aid and challenge drug designers. It will not simply be a matter of using a drug to knock down one key biological player in inflammatory disease. A systems biology approach to this work will enable us to get a complete picture of the biology underpinning inflammation and thus pinpoint the potential axes of control that might be targeted with drugs."

The work is published in Science.

Source: University of Liverpool (news : web)

Explore further: Mice study shows efficacy of new gene therapy approach for toxin exposures

add to favorites email to friend print save as pdf

Related Stories

A Morse code for human cells

Jan 13, 2005

Morse code is a simple, effective and clear method of communication and now scientists believe that cells in our body may also be using patterns of signals to switch genes on and off. The discovery may have major implications ...

New therapy protects lungs from runaway inflammation

Mar 11, 2009

A novel anti-inflammatory therapy designed by Vanderbilt University Medical Center investigators prevents acute lung injury in mice exposed to an inflammation-causing toxin, the researchers report in the journal Molecular Th ...

Recommended for you

How Alzheimer's peptides shut down cellular powerhouses

Aug 29, 2014

The failing in the work of nerve cells: An international team of researchers led by Prof. Dr. Chris Meisinger from the Institute of Biochemistry and Molecular Biology of the University of Freiburg has discovered ...

User comments : 0